12.4100.00% ( 0.000 )
Delay Suspended: Nov 17, 16:08:15Profile
About

MIRXES-B
02629.HK
Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.
Profile
- Company Name
- Mirxes Holding Company Limited
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- mirxes.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
